|Disease||Agent||FDA-Approved Vaccine||Recommended Postexposure Therapy⁎|
|Anthrax||Bacillus anthracis||Biothrax (Bioport Corporation)|
|Smallpox||Variola major||DryVax (Wyeth)||DryVax (Wyeth)¶|
Reprinted with permission from Bartlett JG, Greenberg MI, editors. PDR Guide to Terrorism Response. Montvale, NJ: Thompson PDR; 2005 (16).
FDA = U.S. Food and Drug Administration; VHF = viral hemorrhagic fever.
↵⁎ Only drug names are provided; an antibiotic reference guide should be consulted for the appropriate dose and routes of administration
↵† trivalent vaccine is available but not FDA-approved
↵‡ a live attenuated vaccine is available but not FDA-approved
↵§ yellow fever vaccine available but it is in limited supply and is not considered useful in the setting of a bioterrorist event
↵∥ type-specific equine antitoxins are available but are not recommended for prophylaxis because of their scarcity and high prevalence of severe reactions
↵¶ optimal when administered within 4 days postexposure.